norgestrel (Ovrette)

Introduction

Tradename: Ovrette.

Indications

prevention of pregnancy

Dosage

• 1 tab QD
• start the 1st day of menstruation

Tablets: 0.075 mg

Adverse effects

• common (> 10%)
  • breakthrough bleeding, spotting, changes in menstrual flow, amenorrhea, pain at site of injection, anorexia, edema, weakness
• less common (1-10%)
  • depression, fever, melasma, chloasma, allergic rash with or without pruritus, cholestatic jaundice, changes in cervical erosions & secretions, weight gain or loss, insomnia, breast tenderness

More general terms

• progestational agent

More specific terms

• levonorgestrel (Norplant)
• Norgestrel Oral; norgestrel OTC

Component of

• estradiol/ethinyl estradiol/norgestrel
• ethinyl estradiol/norgestrel
• Ovral (ethinyl estradiol/norgestrel)
• Lo/Ovral

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=13109
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4542
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=62929